Navigation Links
Studies Report Nocturia Was Associated With Risk of Death and Represented a Significant Economic Burden to U.S. Society
Date:6/1/2010

lder), the investigators estimated that the medical cost of falls associated with nocturia (having 2 or more voids / urinations per night) in 2008 was $1.5 billion.(3)

The study was sponsored by Ferring Pharmaceuticals.

About Nocturia  

Nocturia is a commonly-reported cause of sleep disturbance in men and women over the age of 50.(4)  It is also a common lower urinary tract symptom (LUTS).(5) Patients may not seek help because they see nocturia as part of the normal aging process.(6)  Physicians may not recognize nocturnal polyuria, the overproduction of urine at night, as a cause of nocturia.(7,8,9)  The likelihood of developing nocturia increases with age.(10)  Sleep disruptions associated with nocturia can often lead to daytime sleepiness, fatigue, and reduced work productivity, compared with controls.(9,11)

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals Inc. is a subsidiary of Ferring Pharmaceuticals, a privately owned, research-driven Swiss biopharmaceutical company.  Ferring Pharmaceuticals specializes in the research, development and commercialization of peptide compounds in urology, gastroenterology, obstetrics/gynecology, and infertility.  Ferring Pharmaceuticals Inc. offers a line of urology, infertility, gynecology and orthopaedic products in the U.S. market.  

For more information, call 1-888-FERRING (1-888-337-7464) or visit www.FerringUSA.com.

REFERENCES

(1) Kupelian V et al. Nocturia
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
3. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
4. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
5. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
6. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
7. Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
8. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
9. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
10. Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
11. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... DIEGO , Nov. 26, 2014  Aethlon Medical, ... a definitive agreement to raise approximately $3.3 million at ... being made by one institutional healthcare focused investor. Each unit ... of a common share purchase warrant. Each whole warrant ... a price of $0.30 for a period of five ...
(Date:11/26/2014)... 2014 Lexicon Pharmaceuticals, Inc. (Nasdaq: ... previously announced concurrent financing transactions resulting in gross ... offering expenses, Lexicon anticipates net proceeds of approximately ... of: , a public offering of ... registration statement that has been declared effective by ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge has ... VVUS ), Horizon Pharma PLC (NASDAQ: HZNP ... Johnson (NYSE: JNJ ), and Theravance Inc. (NASDAQ: ... can be accessed at: http://investor-edge.com/register . On ... up 0.07%, the Dow Jones Industrial Average edged 0.02% lower, ...
Breaking Medicine Technology:Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
(Date:11/26/2014)... Dr. Rod J. Rohrich, ... in the Department of Plastic Surgery at UT ... fat grafting, and modern lift-and-fill facelifts before colleagues ... held by the American Society of Plastic Surgeons ... facial structure were explored in detail during Dr. ...
(Date:11/26/2014)... Alex Kramer HealthDay ... People with rheumatoid arthritis may be more likely to achieve ... new research. The study found that those who were ... Being underweight also lowered the odds of remission. "Medication ... population," said Dr. Susan Goodman, the study,s lead author and ...
(Date:11/26/2014)... Amy Norton HealthDay Reporter ... people have long believed their dogs understand what they,re saying, ... emotion of words in a human-like way. Past research ... speech -- including the actual content and the emotional tone, ... give a deeper insight into the canine brain, according to ...
(Date:11/26/2014)... Even after they,re cleared to play following a concussion, ... suggests they may not be fully recovered, a new ... may be symptom-free and cleared by MLB [Major League ... of concussion on the complex motor skills required for ... Dr. Jeffrey Bazarian, an associate professor of emergency medicine ...
(Date:11/26/2014)... (HealthDay News) -- More than half of Americans with ... memory skills, a new study suggests. As ... 1.8 million Americans over the age of 70 with ... [mental] abilities," study author Dr. Vikas Kotagal, of the ... in a journal news release. The finding is ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3Health News:Your Dog Really Is Listening to You 2Health News:Your Dog Really Is Listening to You 3Health News:Harm From Baseball Concussions May Linger, Study Finds 2Health News:Too Few Americans Undergo Dementia Screening 2
... Respondents, Lives Significantly Impacted After Breaking a BoneSpecial ... Encourage Women to Make Bone Health a Priority ... The Know My Bones Council today ... which found that one-out-of-five women with postmenopausal osteoporosis ...
... Inc., the global leader in acute ischemic stroke intervention, ... its Merci Registry, a real-world, international, post-market study of ... has enrolled patients from over 30 sites worldwide and ... largest repository of data on mechanical intervention in acute ...
... MONICA, Calif., May 14 Cord Blood America, Inc. (OTC ... company ( http://www.cordblood-america.com ) focused ... families nationwide and internationally, said today it has received a ... its own state-of-the-art laboratory for the storage of multiple stem ...
... reproductive endocrinologist Richard Sherbahn, MD, at the Advanced Fertility Center of ... more eggs retrieved -- but not a correspondingly higher rate of ... ... (PRWeb) May 14, 2009 -- Infertility specialist Richard Sherbahn, MD ...
... MEDITECH and other HIT solutions can use CPMRC,s interdisciplinary clinical content ... ... MI (Vocus) May 14, 2009 -- CPM Resource Center (CPMRC) ... provide small- and medium-sized hospitals with next-generation nursing and interdisciplinary documentation ...
... week, Cimzia(R) (certolizumab pegol), the only pegylated anti-TNF, ... patients suffering from moderately to severely active rheumatoid ... experienced rapid and significant improvements in signs and ... week one, and sustained at week 24 and ...
Cached Medicine News:Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 2Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 3Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 4Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 5Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 6Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 7Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 8Health News:Video: Economic Downturn Is Driving Many Osteoporotic Women to Retire Later - but Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease 9Health News:Concentric Medical Announces Enrollment Milestone for Merci Registry 2Health News:Concentric Medical Announces Enrollment Milestone for Merci Registry 3Health News:Cord Blood America Receives Commitment for $2.3 Million to Fund Its Own Stem Cell Laboratory 2Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 2Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 3Health News:Chicago-area Infertility Specialist Richard Sherbahn, MD, Reports a Woman's Body Mass Index Affects Her Success in Infertility Treatment 4Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 2Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 3Health News:CPM Resource Center and The Shams Group Partner to Help Hospitals Integrate Evidence-Based Clinical Content Into Information Systems 4Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 2Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 3Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 4Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 5Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 6Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 7Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 8Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 9Health News:UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis 10
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: